Jin Yang Pharmaceutical Co. Ltd (007370) — Cash Flow Reinvestment Rate
Jin Yang Pharmaceutical Co. Ltd (007370) has a Cash Flow Reinvestment Rate of 2.39x as of September 2025, reinvesting ₩3.93 Billion (capex ₩1.79 Billion plus investments ₩2.14 Billion) from operating cash flow of ₩1.64 Billion. Explore 007370 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jin Yang Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Jin Yang Pharmaceutical Co. Ltd across 8 annual periods. Also explore Jin Yang Pharmaceutical Co. Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Year-by-year capital reinvestment analysis for Jin Yang Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see Jin Yang Pharmaceutical Co. Ltd (007370) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.67x | ₩3.92 Billion | ₩1.46 Billion | ₩3.67 Billion | ▼ -60.8% |
| 2024 | 6.82x | ₩87.22 Billion | ₩12.79 Billion | ₩947.22 Million | ▲ +1120.0% |
| 2023 | 0.56x | ₩4.77 Billion | ₩8.53 Billion | ₩1.53 Billion | ▼ -62.7% |
| 2022 | 1.50x | ₩11.17 Billion | ₩7.45 Billion | ₩3.22 Billion | ▼ -26.9% |
| 2021 | 2.05x | ₩4.04 Billion | ₩1.97 Billion | ₩2.52 Billion | ▲ +191.0% |
| 2020 | 0.71x | ₩4.41 Billion | ₩6.24 Billion | ₩1.36 Billion | ▲ +198.1% |
| 2019 | 0.24x | ₩1.71 Billion | ₩7.21 Billion | ₩736.71 Million | ▼ -41.7% |
| 2018 | 0.41x | ₩429.64 Million | ₩1.06 Billion | ₩327.39 Million | — |